Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Board Meetings
Prism Medico and Pharmacy Ltd.
 
BSE Code 512217
ISIN Demat INE730E01016
Book Value (Rs.) 25.81
NSE Code NA
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 159.95
TTM PE (x) 26.66
TTM EPS (Rs.) 0.99
Face Value (Rs.) 10  
Source DateBoard Meeting DateDetails
18-Feb-2026 23-Feb-2026 Preferential Issue of shares & Inter alia, to consider the following businesses: 1. Consider and discuss alteration in the Articles of Association of the company subject to approval of shareholders. 2. Consider and discuss the proposal for fund raising by way of preferential issue/private placement of securities for cash, including determination of issue price subject to such regulatory/statutory approvals as may be required, including the approval of shareholders of the company. 3. Consider and discuss any other routine matter or business of the company.
09-Feb-2026 13-Feb-2026 Quarterly Results
06-Nov-2025 14-Nov-2025 Quarterly Results
01-Sep-2025 05-Sep-2025 Inter alia, to consider and approve:- 1. To consider and approve the Director's Report along with all necessary annexures thereof, for the Financial Year ended March 31, 2025; 2. To consider and fix day, date, time for holding the 23rd Annual General Meeting of the company and approve the notice of the same; 3. To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting; 4. To appoint scrutinizer to conduct e-voting and poll process of 23rd Annual General Meeting of the company; 5. To consider and recommend the ratification of appointment of M/s. Garg Mendiratta and Associates, Chartered Accountants as the statutory auditors of the company in place of M/s. Harjeet Parvesh and Company, Chartered Accountants. 6. To consider and discuss any other routine matter or business of the company.
07-Aug-2025 14-Aug-2025 Quarterly Results
20-May-2025 28-May-2025 Quarterly Results & Audited Results
07-Feb-2025 14-Feb-2025 Quarterly Results
07-Nov-2024 14-Nov-2024 Quarterly Results
02-Sep-2024 05-Sep-2024 Inter alia, to consider and approve: 1. To consider and approve the Director's Report along with all necessary annexures thereof, for the Financial Year ended March 31, 2024; 2. To consider and fix day, date, time for holding the 22nd Annual General Meeting of the company and approve the notice of the same; 3. To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting; 4. To appoint scrutinizer to conduct e-voting and poll process of 22nd Annual General Meeting of the company; 5. To consider and recommend the re-appointment of M/s. Harjeet Parvesh and Company, Chartered Accountants as the statutory auditors of the company. 6. To recommend the appointment of Mr. Hitendra Shamji Hirani (DIN: 10427309) as a Director of the company. 7. To recommend the appointment of Mr. Jay Hitendra Hirani (DIN: 10435245) as a Director of the company. 8. To consider and discuss any other routine matter or business of the company.
07-Aug-2024 14-Aug-2024 Quarterly Results
close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :
Assamese Bengali Gujarati Hindi Kanada Kashmiri Konkani Malyalam Marathi Oriya Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
ATTENTION INVESTORS :
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...................... issued in the interest of investors.
ATTENTION INVESTORS :
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.